Diovan HCT Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows Diovan HCT U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q3 2012 | 34 ( 2) |
$372,714 | -7.39% | 1,405 | 16.21% |
| Q2 2012 | 36 ( 2) |
$402,445 | -3.14% | 1,209 | -3.36% |
| Q1 2012 | 34 (6) |
$415,475 | 9.52% | 1,251 | -3.77% |
| Q4 2011 | 40 (8) |
$379,367 | -1.99% | 1,300 | -1.52% |
| Q3 2011 | 32 (1) |
$387,064 | -8.54% | 1,320 | -7.76% |
| Q2 2011 | 31 (3) |
$423,209 | 4.51% | 1,431 | -2.12% |
| Q1 2011 | 34 | $404,945 | n/a | 1,462 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
